FDA approves Nevro’s Senza Omnia spinal cord stimulation system
Senza Omnia delivers Nevro's HF10 therapy and all other available SCS frequencies
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
06 Nov 19
Senza Omnia delivers Nevro's HF10 therapy and all other available SCS frequencies
05 Nov 19
The device is the first of Its kind biomaterial poised to disrupt the PEEK and titanium implant market
01 Nov 19
Shreis, while actively pursuing collaborations for clinical trials in the current proposed indications for use, intend to also…
01 Nov 19
Sahara Lateral is claimed to be first ever 3D-printed lateral expandable fusion device
30 Oct 19
The Oxalert EPO arousal device exists now as a simple user-friendly wrist-worn battery-operated arousal system
Currently, LVAD systems include an implanted heart pump to increase the amount of blood that circulates through the…
30 Oct 19
The Sundance SCB will enhance the endovascular revascularisation options for below-the-knee arterial lesions in patients suffering from critical…
25 Oct 19
INVOcell is currently FDA-approved and being distributed in the US under a separate agreement with Ferring Pharmaceuticals
25 Oct 19
This FDA designation is a process aimed at fast-forwarding clinical development and regulatory review of the CoFI system
23 Oct 19
BioPrax device will help eliminate biofilm infections on prosthetic knee implants during early intervention procedures